Mobilization Test of BM Progenitor Cells With Plerixafor/AMD3100: Controlled Parallel Group Comparison Between Diabetic and Non Diabetic Subjects

Trial Profile

Mobilization Test of BM Progenitor Cells With Plerixafor/AMD3100: Controlled Parallel Group Comparison Between Diabetic and Non Diabetic Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2015

At a glance

  • Drugs Plerixafor (Primary)
  • Indications Stem cell mobilisation
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Mar 2015 Results of pooled analysis of this trial and two retrospective trials have been published in the Diabetes.
    • 23 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top